Salarius Pharmaceuticals | 10-Q:季度报表
Salarius Pharmaceuticals | 10-K/A:年度报表(修正版)
Salarius Pharmaceuticals | 4:持股变动声明-高管 Arthur David J.
Salarius Pharmaceuticals | DEFA14A:其他
Salarius Pharmaceuticals | DEF 14A:股东委托书决议
Salarius Pharmaceuticals | 10-K:年度报表
Salarius Pharmaceuticals | DFAN14A:其他委托征集材料
Salarius Pharmaceuticals | PRE 14A:并购重组委托声明
Salarius Pharmaceuticals | 8-K:重大事件
Salarius Pharmaceuticals | 8-K:重大事件
Salarius Pharmaceuticals | 4:持股变动声明-高管 Rosenblum Mark J
Salarius Pharmaceuticals | 4:持股变动声明-董事 Lieber Jonathan I
Salarius Pharmaceuticals | 4:持股变动声明-董事 McVicar William K.
Salarius Pharmaceuticals | 4:持股变动声明-董事 McCreedy Bruce J Jr.
Salarius Pharmaceuticals | 4:持股变动声明-董事 Burleson Tess
Salarius Pharmaceuticals | 4:持股变动声明-董事 Lammers Paul
Salarius Pharmaceuticals | 4:持股变动声明-董事 HANISH ARNOLD C
Salarius Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Salarius Pharmaceuticals:2023财年三季报
Salarius Pharmaceuticals | SC 13D:超过5%持股股东披露文件-Elvin Lee(6.09%)
暂无数据